JP2025508820A5 - - Google Patents
Info
- Publication number
- JP2025508820A5 JP2025508820A5 JP2024550131A JP2024550131A JP2025508820A5 JP 2025508820 A5 JP2025508820 A5 JP 2025508820A5 JP 2024550131 A JP2024550131 A JP 2024550131A JP 2024550131 A JP2024550131 A JP 2024550131A JP 2025508820 A5 JP2025508820 A5 JP 2025508820A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- gglu
- valine
- aib
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22158188.7A EP4234574A1 (en) | 2022-02-23 | 2022-02-23 | Crf2 receptor agonists and their use in therapy |
| EP22158188.7 | 2022-02-23 | ||
| PCT/EP2023/054317 WO2023161229A1 (en) | 2022-02-23 | 2023-02-21 | Crf2 receptor agonists and their use in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508820A JP2025508820A (ja) | 2025-04-10 |
| JP2025508820A5 true JP2025508820A5 (https=) | 2025-12-23 |
Family
ID=80819682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024550131A Pending JP2025508820A (ja) | 2022-02-23 | 2023-02-21 | Ｃｒｆ２受容体アゴニスト及び治療法におけるそれらの使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20260001928A1 (https=) |
| EP (2) | EP4234574A1 (https=) |
| JP (1) | JP2025508820A (https=) |
| KR (1) | KR20240153565A (https=) |
| CN (1) | CN118843638A (https=) |
| AU (1) | AU2023224327A1 (https=) |
| CA (1) | CA3247142A1 (https=) |
| ES (1) | ES3063881T3 (https=) |
| HR (1) | HRP20260115T1 (https=) |
| IL (1) | IL314055A (https=) |
| IS (1) | IS050770A (https=) |
| MX (1) | MX2024010296A (https=) |
| PL (1) | PL4482578T3 (https=) |
| WO (1) | WO2023161229A1 (https=) |
| ZA (1) | ZA202406196B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025104264A1 (en) * | 2023-11-17 | 2025-05-22 | Gubra A/S | Hcrhr2 selective polypeptides |
| WO2026064495A1 (en) * | 2024-09-20 | 2026-03-26 | Neurocrine Biosciences, Inc. | Chemically modified peptides and use thereof |
| WO2026064486A1 (en) * | 2024-09-20 | 2026-03-26 | Neurocrine Biosciences, Inc. | Chemically modified peptides and use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008047241A2 (en) * | 2006-10-16 | 2008-04-24 | Conjuchem Biotechnologies Inc. | Modified corticotropin releasing factor peptides and uses thereof |
| JOP20170153A1 (ar) | 2016-07-15 | 2019-01-30 | Lilly Co Eli | نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة |
| WO2019140030A1 (en) * | 2018-01-12 | 2019-07-18 | Eli Lilly And Company | Combination therapy |
| US20250243255A1 (en) * | 2020-08-19 | 2025-07-31 | Sanofi | Crf2 receptor agonists and their use in therapy |
-
2022
- 2022-02-23 EP EP22158188.7A patent/EP4234574A1/en not_active Withdrawn
-
2023
- 2023-02-21 AU AU2023224327A patent/AU2023224327A1/en active Pending
- 2023-02-21 MX MX2024010296A patent/MX2024010296A/es unknown
- 2023-02-21 US US18/839,784 patent/US20260001928A1/en active Pending
- 2023-02-21 HR HRP20260115TT patent/HRP20260115T1/hr unknown
- 2023-02-21 CN CN202380019995.3A patent/CN118843638A/zh active Pending
- 2023-02-21 CA CA3247142A patent/CA3247142A1/en active Pending
- 2023-02-21 ES ES23705580T patent/ES3063881T3/es active Active
- 2023-02-21 IL IL314055A patent/IL314055A/en unknown
- 2023-02-21 EP EP23705580.1A patent/EP4482578B1/en active Active
- 2023-02-21 PL PL23705580.1T patent/PL4482578T3/pl unknown
- 2023-02-21 KR KR1020247028787A patent/KR20240153565A/ko active Pending
- 2023-02-21 JP JP2024550131A patent/JP2025508820A/ja active Pending
- 2023-02-21 WO PCT/EP2023/054317 patent/WO2023161229A1/en not_active Ceased
-
2024
- 2024-08-13 ZA ZA2024/06196A patent/ZA202406196B/en unknown
- 2024-09-18 IS IS050770A patent/IS050770A/is unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025508820A5 (https=) | ||
| HRP20240906T1 (hr) | Agonisti crf2 receptora i njihova primjena u terapiji | |
| JP2023541798A5 (https=) | ||
| US9221871B2 (en) | Methods for preparing internally constrained peptides and peptidomimetics | |
| PE20231841A1 (es) | Coagonistas de los receptores glp-1 y gip adecuados para el suministro oral | |
| JP2012512901A5 (https=) | ||
| HK1209764A1 (en) | Glucagon analogs exhibiting gip receptor activity | |
| CN102458438A (zh) | 具有肽骨架和c-末端修饰的经修饰补体抑素 | |
| CA2931694C (en) | Fatty acid derivatives of dimeric peptide ligands of psd-95 and use thereof for treating excitotoxic disease | |
| EP4482578B1 (en) | Crf2 receptor agonists and their use in therapy | |
| JP2016519106A5 (https=) | ||
| US9850285B2 (en) | Process for preparing eptifibatide | |
| DE602008004897D1 (de) | Verbindungen zur diagnose von mit der vcam-expression assoziierten krankheiten | |
| RU2726414C2 (ru) | Новые способы получения барусибана и его промежуточных соединений | |
| RU2024126937A (ru) | Агонисты рецепторов crf2 и их применение в терапии | |
| JP2633369B2 (ja) | ペプチド | |
| WO2017149098A1 (en) | Fusion respiratory syncytial virus inhibitors and use thereof | |
| JP2017512760A (ja) | 環状アペリン類似体 | |
| JP7218906B2 (ja) | 血管機能の検出方法、高血圧症の進行段階を判定する方法、高血圧症の進行段階を判定するためのキット及び高血圧症の治療効果の予測方法 | |
| WO2025043696A1 (zh) | 抗病毒多肽类似物 | |
| TW202511281A (zh) | 抗病毒多肽類似物 | |
| JPWO2025142861A5 (https=) | ||
| AU629826C (en) | Peptides | |
| JPS6241508B2 (https=) |